Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.1493 USD
−34.90 M USD
35.70 M USD
596.35 M
About Hua Medicine Ltd.
Sector
Industry
CEO
Li Chen
Website
Headquarters
Shanghai
Founded
2009
IPO date
Sep 14, 2018
Identifiers
3
ISIN KYG4644K1022
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HUMDF is 0.4107 USD — it has increased by 173.80% in the past 24 hours. Watch Hua Medicine stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hua Medicine stocks are traded under the ticker HUMDF.
HUMDF reached its all-time high on Mar 17, 2021 with the price of 0.7000 USD, and its all-time low was 0.1500 USD and was reached on Sep 27, 2024. View more price dynamics on HUMDF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HUMDF stock is 63.48% volatile and has beta coefficient of 2.36. Track Hua Medicine stock price on the chart and check out the list of the most volatile stocks — is Hua Medicine there?
Today Hua Medicine has the market capitalization of 394.23 M, it has decreased by −4.87% over the last week.
Yes, you can track Hua Medicine financials in yearly and quarterly reports right on TradingView.
Hua Medicine is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
HUMDF net income for the last half-year is 161.96 M USD, while the previous report showed −15.06 M USD of net income which accounts for 1.18 K% change. Track more Hua Medicine financial stats to get the full picture.
No, HUMDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 168 employees. See our rating of the largest employees — is Hua Medicine on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hua Medicine EBITDA is −27.17 M USD, and current EBITDA margin is −127.29%. See more stats in Hua Medicine financial statements.
Like other stocks, HUMDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hua Medicine stock right from TradingView charts — choose your broker and connect to your account.